NCT04670328View on ClinicalTrials.gov

Role of Hematological Parameters in the Stratification of COVID-19 Disease Severity

CompletedOBSERVATIONAL
Enrollment

101

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

July 31, 2020

Study Completion Date

July 31, 2020

Conditions
Covid19
Interventions
DIAGNOSTIC_TEST

not required

Diagnostic tests( hematological parameters) were assessed.

Trial Locations (1)

54000

FMH college of medicine and dentistry, Lahore

All Listed Sponsors
lead

FMH College of Medicine and Dentistry

OTHER

NCT04670328 - Role of Hematological Parameters in the Stratification of COVID-19 Disease Severity | Biotech Hunter | Biotech Hunter